Witzeman Michael D — SEC insider filings
SEC reporting owner CIK 1699624. 22 insider filings on record with FilingPulse; latest filed 2026-10-22.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-10-30 to 2026-10-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 8,186 shares, $4,513,331 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 64.
- Largest priced transaction: sale of 2,650 shares @ $643.14 ($1,704,321) in CHEMED CORP, filed 2024-03-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHEMED CORP (CHE) | VP & Chief Financial Officer | 22 | — | 5 legs · 8,186 sh · $4,513,331 | 64 |
Insider filings — Witzeman Michael D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-22 | 4 | CHEMED CORP (CHE) | Grant/award (A): 12,686 (derivative) @ $512.64 | EDGAR |
| 2026-02-17 | 4 | CHEMED CORP (CHE) | Option exercise (M): 413 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 120 @ $469.56 · Option exercise (M): 333 (derivative) @ $0 · Option exercise (M): 333 (derivative) @ $0 · Grant/award (A): 1,394 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | CHEMED CORP (CHE) | Grant/award (A): 19,486 (derivative) @ $443.79 | EDGAR |
| 2025-03-11 | 4 | CHEMED CORP (CHE) | Option exercise (M): 8,796 @ $445.35 · Tax withholding (F): 7,494 @ $600.92 · Option exercise (M): 8,796 (derivative) @ $445.35 | EDGAR |
| 2025-02-18 | 4 | CHEMED CORP (CHE) | Option exercise (M): 652 @ $553.39 · Option exercise (M): 198 @ $553.39 · Tax withholding (F): 276 @ $553.39 · Option exercise (M): 323 (derivative) @ $0 · Option exercise (M): 323 (derivative) @ $0 · Grant/award (A): 1,128 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | CHEMED CORP (CHE) | Grant/award (A): 13,395 (derivative) @ $597.70 | EDGAR |
| 2024-08-01 | 4 | CHEMED CORP (CHE) | Option exercise (M): 7,948 @ $471.74 · Tax withholding (F): 7,225 @ $560.99 · Option exercise (M): 7,948 (derivative) @ $471.74 | EDGAR |
| 2024-05-09 | 4 | CHEMED CORP (CHE) | Option exercise (M): 1,100 @ $413.19 · Tax withholding (F): 921 @ $576.95 · Option exercise (M): 1,100 (derivative) @ $413.19 | EDGAR |
| 2024-03-22 | 4 | CHEMED CORP (CHE) | Option exercise (M): 2,600 @ $413.19 · Tax withholding (F): 355 @ $647.44 · Sale (S): 2,650 @ $643.14 · Option exercise (M): 2,600 (derivative) @ $413.19 | EDGAR |
| 2024-02-20 | 4 | CHEMED CORP (CHE) | Option exercise (M): 173 @ $586.49 · Option exercise (M): 260 @ $586.49 · Tax withholding (F): 130 @ $586.49 · Option exercise (M): 278 (derivative) @ $0 · Option exercise (M): 278 (derivative) @ $0 · Grant/award (A): 942 (derivative) @ $0 | EDGAR |
| 2023-11-08 | 4 | CHEMED CORP (CHE) | Option exercise (M): 3,300 @ $413.19 · Tax withholding (F): 2,685 @ $582.95 · Option exercise (M): 3,300 (derivative) @ $413.19 | EDGAR |
| 2023-10-26 | 4 | CHEMED CORP (CHE) | Grant/award (A): 12,540 (derivative) @ $509.46 | EDGAR |
| 2023-02-22 | 4 | CHEMED CORP (CHE) | Option exercise (M): 426 @ $515.12 · Option exercise (M): 243 @ $515.12 · Tax withholding (F): 200 @ $515.12 · Option exercise (M): 211 (derivative) @ $0 · Option exercise (M): 211 (derivative) @ $0 · Grant/award (A): 666 (derivative) @ $0 | EDGAR |
| 2022-11-14 | 4 | CHEMED CORP (CHE) | Sale (S): 736 @ $498.47 | EDGAR |
| 2022-11-04 | 4 | CHEMED CORP (CHE) | Sale (S): 1,300 @ $482.62 · Option exercise (M): 6,900 @ $306.70 · Tax withholding (F): 5,450 @ $479.27 · Option exercise (M): 6,900 (derivative) @ $306.70 | EDGAR |
| 2022-11-02 | 4 | CHEMED CORP (CHE) | Grant/award (A): 8,549 (derivative) @ $462.04 | EDGAR |
| 2022-02-23 | 4 | CHEMED CORP (CHE) | Option exercise (M): 543 @ $459.77 · Option exercise (M): 354 @ $459.77 · Tax withholding (F): 266 @ $459.77 · Option exercise (M): 269 (derivative) @ $0 · Option exercise (M): 269 (derivative) @ $0 · Grant/award (A): 646 (derivative) @ $0 | EDGAR |
| 2021-11-02 | 4 | CHEMED CORP (CHE) | Grant/award (A): 8,796 (derivative) @ $445.35 | EDGAR |
| 2021-02-23 | 4 | CHEMED CORP (CHE) | Option exercise (M): 596 @ $491.34 · Option exercise (M): 486 @ $491.34 · Tax withholding (F): 322 @ $491.34 · Option exercise (M): 295 (derivative) @ $0 · Option exercise (M): 295 (derivative) @ $0 · Grant/award (A): 556 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | CHEMED CORP (CHE) | Sale (S): 2,500 @ $520 | EDGAR |
| 2020-11-05 | 4 | CHEMED CORP (CHE) | Option exercise (M): 8,000 @ $231.91 · Sale (S): 1,000 @ $514.73 · Tax withholding (F): 5,551 @ $492.38 · Option exercise (M): 8,000 (derivative) @ $231.91 | EDGAR |
| 2020-10-30 | 4 | CHEMED CORP (CHE) | Grant/award (A): 7,948 (derivative) @ $471.74 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1699624 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs